These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
39 related articles for article (PubMed ID: 8753319)
21. Localization of a vasoactive intestinal peptide-producing tumor with selective venous sampling. Smith FR; Rogers AI Am J Gastroenterol; 1980 Sep; 74(3):282-4. PubMed ID: 7468568 [TBL] [Abstract][Full Text] [Related]
22. Long-acting analogue of vasoactive intestinal peptide, [R15, 20, 21, L17]-VIP-GRR (IK312532), protects rat alveolar L2 cells from the cytotoxicity of cigarette smoke. Onoue S; Endo K; Ohmori Y; Yamada S; Kimura R; Yajima T; Kashimoto K Regul Pept; 2004 Dec; 123(1-3):193-9. PubMed ID: 15518912 [TBL] [Abstract][Full Text] [Related]
23. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation. Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D J Immunol; 1999 Apr; 162(8):4685-96. PubMed ID: 10202009 [TBL] [Abstract][Full Text] [Related]
24. Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide stimulate interleukin-6 production in prostate cancer cells and prostatic epithelial cells. Nagakawa O; Junicho A; Akashi T; Koizumi K; Matsuda T; Fuse H; Saiki I Oncol Rep; 2005 Jun; 13(6):1217-21. PubMed ID: 15870945 [TBL] [Abstract][Full Text] [Related]
25. Prolactin release induced by physical exercise is independent from peripheral vasoactive intestinal polypeptide secretion. Rolandi E; Reggiani E; Franceschini R; Arras GB; Cataldi A; de Lucia F; Barreca T Ann Clin Res; 1988; 20(6):428-30. PubMed ID: 3218916 [TBL] [Abstract][Full Text] [Related]
27. Vasoactive intestinal peptide and nitric oxide (NO) in the acute phase following burns and trauma. Harper R; Martin R Burns; 2002 May; 28(3):288; author reply 289. PubMed ID: 11996867 [No Abstract] [Full Text] [Related]